Dr. Anne E. Chang-Godinich, MD

Dr. Chang-Godinich practices at 1960 Eye Surgeons, P.A. in Houston, Texas.

Dr. Chang-Godinich's NPI, 1760479596, was assigned on October 6, 2005. Dr. Chang-Godinich graduated from Baylor College Of Medicine in 1995. Dr. Chang-Godinich's Texas license number on file is K1173.

Dr. Chang-Godinich's primary practice is 1960 Eye Surgeons, P.A., at 13333 Dotson Rd, Houston, TX 77070 in Harris County. The practice phone is (281) 890-1784.

Dr. Chang-Godinich's primary practice is 1960 Eye Surgeons, P.A. in Houston, Texas. Dmand AI also links Dr. Chang-Godinich to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chang-Godinich practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Chang-Godinich's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Chang-Godinich is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Chang-Godinich has a license on file in Texas.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Dr. Chang-Godinich treats.

CMS data shows 902 Medicare services from Dr. Chang-Godinich across 13 procedure codes in 2024, for 371 Medicare patients. Medicare paid $76,784 for them.

CMS counts 371 Medicare patients who saw Dr. Chang-Godinich in 2024. The largest group is 65 to 74, with 178 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chang-Godinich's median patient age at 73, with 60% women.

In 2024, Dr. Chang-Godinich wrote 681 Medicare Part D claims for 190 patients. 50% of them were for generic drugs. CMS names the drug for 601 of them, across 12 drugs with 11 or more claims each, at $59,257 in total drug cost. In 2023, CMS named 700 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Chang-Godinich for performance year 2024, reported as part of a group. Dr. Chang-Godinich accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 77 procedures of cataract surgery by Dr. Chang-Godinich, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Chang-Godinich. The most frequent topics are Visual Acuity and Cornea. Dr. Chang-Godinich has published most often in J Cataract Refract Surg. Dr. Chang-Godinich's most frequent co-authors are Douglas D. Koch, MD and Richard J. Ou, MD.

CMS Open Payments shows 113 general payments to Dr. Chang-Godinich from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Shire North American Group Inc paid the most, $448.

Dr. Chang-Godinich graduated from Baylor College Of Medicine in 1995.

Dr. Chang-Godinich is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.